GeneDx Holdings Corp (NASDAQ:WGS) price on Wednesday, February 05, fall -6.72% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $67.18.
A look at the stock’s price movement, the close in the last trading session was $72.02, moving within a range at $60.35 and $76.13. The beta value (5-Year monthly) was 2.18. Turning to its 52-week performance, $98.87 and $3.63 were the 52-week high and 52-week low respectively. Overall, WGS moved -15.11% over the past month.
GeneDx Holdings Corp’s market cap currently stands at around $1.85 billion, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 82.24M for the company’s revenue for the quarter, with a low and high estimate of 78.2M and 92.11M respectively. The average forecast suggests up to a 43.23% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 290.82M, representing a 43.57% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that WGS is a Hold. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend WGS as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
WGS’s current price about -13.25% and -13.31% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 40.11, while 7-day volatility ratio is 11.74% and 10.45% in the 30-day chart. Further, GeneDx Holdings Corp (WGS) has a beta value of 2.08, and an average true range (ATR) of 7.24. Analysts have given the company’s stock an average 52-week price target of $52, forecast between a low of $34 and high of $70. Looking at the price targets, the low is 49.39% off current price level while to achieve the yearly target high, price needs to move -4.2%. Nonetheless, investors will most likely welcome a 22.6% jump to $52 which is the analysts’ median price.
If we refocus on GeneDx Holdings Corp (NASDAQ:WGS), historical trading data shows that trading volumes averaged 0.7 over the past 10 days and 659.16K over the past 3 months. The company’s latest data on shares outstanding shows there are 27.43 million shares.
The 19.68% of GeneDx Holdings Corp’s shares are in the hands of company insiders while institutional holders own 67.57% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 2.14 million on 2025-01-15, giving us a short ratio of 2.73. The data shows that as of 2025-01-15 short interest in GeneDx Holdings Corp (WGS) stood at 2049.0 of shares outstanding, with shares short falling to 2.15 million registered in 2024-12-13. Current price change has pushed the stock -12.59% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the WGS stock continues to rise going into the next quarter.
